Table of Contents
ISRN Endocrinology
Volume 2013, Article ID 148497, 9 pages
http://dx.doi.org/10.1155/2013/148497
Clinical Study

Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance

Department of Molecular Medicine and Surgery, D2:04, Karolinska Institutet and Karolinska University Hospital, 17176 Stockholm, Sweden

Received 27 November 2012; Accepted 19 December 2012

Academic Editors: C. Anderwald, F. Escobar-Jimenez, T. W. Furlanetto, P. Morosini, and H. Tamemoto

Copyright © 2013 Lisa Arnetz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lisa Arnetz, Neda Rajamand Ekberg, Charlotte Höybye, Kerstin Brismar, and Michael Alvarsson, “Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance,” ISRN Endocrinology, vol. 2013, Article ID 148497, 9 pages, 2013. https://doi.org/10.1155/2013/148497.